$1.50
▼ -4.5% Today
as of Oct 23, 16:49 ET
Last 30 days
Recent Press Releases & News
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update
Down 22% in 4 Weeks, Here's Why Innate Pharma (IPHA) Looks Ripe for a Turnaround
IPHA earnings at a glance
The share price of $1.50 sits in the middle of its 52-week range.
Overview
52-week range
$1.17
$2.71
21% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for IPHA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.